Home Blog Page 2597

Ecolab and SCG Sign MOU to Enhance Business Competitiveness and Drive ESG Progress Toward Net Zero

BANGKOK, Sept. 1, 2025 /PRNewswire/ — Ecolab, a global leader in water, hygiene, and infection prevention solutions and services, and SCG (Siam Cement Group), ASEAN’s leading business conglomerate, have signed a Memorandum of Understanding (MOU) in view of five year partnership to strengthen SCG’s competitiveness through efficiency gains and cost savings, while advancing its ESG strategy as a pathway to Net Zero. Running from June 2025 to May 2030, the agreement will help SCG reduce its greenhouse gas emissions and increase its water reuse ratio beyond the 13.10% baseline in 2024. This MOU builds on a 30-year partnership that continues to deliver impactful innovations in sustainability, efficiency, and environmental stewardship. 

SCG President and CEO, Thammasak Sethaudom & Ecolab Chairman and CEO, Christophe Beck
SCG President and CEO, Thammasak Sethaudom & Ecolab Chairman and CEO, Christophe Beck

Building on this foundation, the MOU focuses on outcomes that strengthen competitiveness — from optimizing water use to significantly cutting CO₂ emissions within the next five years, while improving efficiency to lower operational costs. Ecolab will partner with SCG Packaging (SCGP) and SCG Chemicals (SCGC) to explore potential initiatives that deliver more efficient and productive processes with high-quality output. Through innovative solutions and process improvements, operations will not only save water, reduce footprint, and enhance water quality, but also lower energy consumption, improve energy efficiency, and explore opportunities for renewable energy integration — ultimately driving sustainability impact alongside long-term business resilience.

Christophe Beck, Chairman and CEO of Ecolab, said, “For more than 30 years, Ecolab has been proud to support SCG and their sustainability journey. Our long-standing collaboration has been grounded in a shared belief that responsible business practices can both protect our planet and create long-term value for companies and communities.

Through our water solutions and process expertise, we’ve become a trusted partner that helps SCG deliver measurable outcomes. As we look ahead, we’re confident that our continued collaboration—powered by innovation and a focus on sustainable growth—will help accelerate SCG’s environmental ambitions and inspire progress across the broader industry. I look forward to seeing what we can accomplish together.”

Thammasak Sethaudom, President and Chief Executive Officer of SCG, said, “At SCG, we believe competitiveness and sustainability go hand in hand. This MOU with Ecolab is a strategic move that enables us to reduce costs, improve efficiency, and strengthen our resilience by increasing our water reuse ratio beyond 13.10% in 2024 and reducing greenhouse gas emissions, while advancing our ESG priorities as the foundation towards Net Zero 2050. Partnering with a global leader like Ecolab demonstrates how collaboration can create shared value through knowledge exchange and innovation at a world-class level. To begin, this collaboration will involve SCGP and SCGC, with the potential for other businesses to join as opportunities arise.”

Danaidej Ketsuwan, Chief Financial Officer, SCGP, added, “For SCGP, this partnership supports our commitment to deliver sustainable packaging solutions. By integrating circular design principles and resource efficiency with Ecolab’s expertise, we will create packaging that minimizes environmental impact and adds value for our customers and communities.”

Dr.Suracha Udomsak, Chief Operations and Innovation Officer, SCGC, added, “For SCGC, the collaboration is an opportunity to further advance water and energy efficiency across our operations. This collaboration aligns with SCGC’s sustainability commitment of ‘Low Waste, Low Carbon’, while strengthening our competitiveness.”

This five-year MOU underscores how collaboration between industry leaders can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening competitiveness across industries.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets. www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

About SCG

SCG, now in its 112th year, is a leading business conglomerate in ASEAN. With strong resilience and advanced technology, the Company delivers innovative products, services, and solutions that meet diverse needs and adapt to fast-changing markets through its core businesses: Cement and Building Materials, Chemicals (SCGC), and Packaging (SCGP), as well as new businesses such as Clean Energy (SCG Cleanergy). Committed to improving quality of life and a sustainable future, SCG embeds ESG principles across Thailand, ASEAN, and globally, underpinned by trust, transparency, and its purpose of “Inclusive Green Growth.”

Follow us on Website https://www.scg.com/, LinkedIn @SCG, Instagram @scg.officialig and Facebook @ SCGofficialpage.

(Executives from left to right): SCGP CFO, Danaidej Ketsuwan; SCG Smart Living and SCG Distribution & Retail President, Wiroat Rattanachaisit; SCG Cement & Green Solution President, Surachai Nimlaor; SCGC Chief Operations and Innovation Officer, Dr.Suracha Udomsak; SCG President and CEO, Thammasak Sethaudom; Ecolab Chairman & CEO, Christophe Beck; SVP& Market Head, Greg Lukasik; Chief Marketing & Innovation Officer, Chris Leong, VP & GM for Basic Industries; Chandrasegaran Marimuthu and Strategic Account Director, Chroong Kanjchanapoomi
(Executives from left to right): SCGP CFO, Danaidej Ketsuwan; SCG Smart Living and SCG Distribution & Retail President, Wiroat Rattanachaisit; SCG Cement & Green Solution President, Surachai Nimlaor; SCGC Chief Operations and Innovation Officer, Dr.Suracha Udomsak; SCG President and CEO, Thammasak Sethaudom; Ecolab Chairman & CEO, Christophe Beck; SVP& Market Head, Greg Lukasik; Chief Marketing & Innovation Officer, Chris Leong, VP & GM for Basic Industries; Chandrasegaran Marimuthu and Strategic Account Director, Chroong Kanjchanapoomi

Jenscare, releases 2025H1 interim results

BEIJING, Sept. 1, 2025 /PRNewswire/ — Jenscare Scientific Co., Ltd. (“Jenscare” or the “Company”) (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 ended June 30, 2025.

Business Overviews:

In 2025H1, significant progress was achieved across its product pipeline in the interventional treatment for tricuspid, aortic and mitral valve diseases, establishing a diversified and high-potential product portfolio. More importantly, the Company continued to expand its global business layout, enhancing product influence and clinical application scale, thereby laying a solid foundation for sustainable high-speed growth.

The global registration and clinical progress of LuX-Valve Plus TTVR system achieves key milestones in China, Europe, and U.S.

In China, the multicenter registration clinical trial of LuX-Valve Plus is in the long-term follow-up phase and shows excellent clinical results. Randomized controlled trial (RCT) of optimized medical therapy (OMT) conducted in China has completed subject enrollment. The application for NMPA registration has been submitted and accepted, entering registration review stage. The Company is actively advancing the NMPA registration process of LuX-Valve Plus and strives to obtain the NMPA registration certificate soon.

In Europe, LuX-Valve Plus has completed 6-month follow-up of the global multicenter clinical trial TRINITY Study for CE Marking and is currently under registration review. The 30-day clinical follow-up results of TRINITY Study were officially released at EuroPCR 2025, indicating favorable clinical results. The 30-day clinical follow-up results in large annulus patients in the TRNITY Study were released at New York Valves 2025. The results showed that both groups of patients (large annulus patients and small annulus patients) demonstrated outstanding outcomes. The wide range of application of LuX-Valve Plus provides an excellent treatment option, particularly for patients of annular dilation with severe TR. The 6-month follow-up outcome of TRINITY Study is expected to be released at TCT 2025.

In the United States, LuX-Valve Plus was selected to participate in the FDA’s Total Product Life Cycle Advisory Program (TAP) pilot. Its FDA IDE early feasibility study (EFS) has completed subject enrollment and has received reimbursement for device and related costs from CMS. The Company is actively advancing the progress to obtain approval for the Pivotal Study.

The commercialization of Ken-Valve TAVR system is advancing rapidly, with continuous growth in both hospital coverage and implantations

Ken-Valve has quickly gained market access after its approval by NMPA in 2025H1. The Company has been actively promoting the commercialization activities with smooth progress in hospital adoption. Commercial implantations are being actively conducted across the country.

Ken-Valve has received plenty of positive feedbacks regards its innovative design, operational performance, and clinical efficacy. It is a rare product that is indicated for severe AR (or combined with AS) to meet large underpenetrated clinical needs. Its innovative design accommodates a wide range of complex anatomies, significantly improving procedural safety and flexibility while reducing device operation time. The large-size valves of 29mm, 31mm, and 33mm have been widely recognized by physicians and the market, addressing the unmet clinical need for large-annulus patients. It is also suitable for patients with challenging anatomies, such as severe horizonal heart. The average device operation time was less than 10 minutes, with the shortest being around 4 minutes during the commercialization phase.

We will continue to advance the commercialization of Ken-Valve, leveraging its differentiated competitive advantages, supply chain strengths, and flexible marketing strategies to provide the Company with stable revenue and profits.

JensClip TMVr system has submitted its NMPA registration application

JensClip has submitted its NMPA registration application, entering the registration stage. The one-year clinical follow-up results were released at EuroPCR 2025, showing encouraging efficacy and safety indicators.

The globalization process is being actively pursued. Pre-commercialization implantations have been successfully conducted overseas, with all procedures progressing smoothly and the product demonstrating excellent performance. CE Marking activities are also underway

Global commercialization strategy

  • Differentiated Positioning of competitive product portfolio

Our product portfolio leverages diversified, innovative designs to address vast, under-penetrated, and rapidly growing markets. Through differentiated product positioning, we quickly build brand recognition; stable, user-friendly operation of the products rapidly establishes physician habits. Leveraging global KOLs and proctors with extensive experience and academic influence, we disseminate procedural skills and technical expertise via diverse academic conferences, live/recorded cases, and case discussions—radiating from leaders to regional centers to expand product awareness and hospital coverage at speed.

  • Global Sales Network

In China, we have established a comprehensive regional distributor network for Ken-Valve, supported by flexible pricing and sales strategies that allow agile, timely responses to market dynamics to accelerate commercialization and expand market share. Overseas, commercial preparations for LuX-Valve Plus are ongoing, with in-depth market research laying the groundwork for imminent market launch.

  • Professional Procedural Promotion

A dedicated, high-efficiency commercial team drives market entry, procedural education, and marketing for our products. Through high-standard on-site clinical support and feedback, we ensure consistently high-quality procedures worldwide, enhance customer satisfaction, and establish global procedural standards. Active participation in premier structural-heart conferences, associations, and annual conferences across the globe further elevates brand influence and academic standing.

  • Comprehensive Training System

We have built robust internal and external training programs that deliver thorough, professional instruction on product features, procedural techniques, imaging applications, perioperative management, and complex-case handling—accelerating procedural adoption both inside and outside the organization and driving rapid product penetration and market-share expansion.

Future Expectations

The Company will continue to advance the clinical and commercial development of multiple products, striving to become a high-potential medical device enterprise with a global vision and l business layout.

We will accelerate the worldwide rollout of the LuX-Valve series, aiming to set the leading benchmark in transcatheter tricuspid-valve intervention. Leveraging its global partnerships, clinical application experience, and brand reputation, the Company will extend overseas opportunities across its entire product portfolio.

To achieve sustainable rapid growth, we aim to further expand and optimize our product portfolio to address the substantial and urgent unmet clinical needs in structural heart disease treatment.

By further enhancing operational efficiency, rapidly capturing high-growth revenue and profit, and sustaining innovation, the Company will secure long-term success for its globalization strategy.

Financial Highlights: Steady Operation with High Quality of Growth

  • Total revenue was RMB 26 million (US$ 3.6 million)[1], marking a great start for commercialization. Gross profit and sales profit[2] was RMB 12 million (US$ 1.7 million) and RMB 8 million (US$ 1.1 million) respectively, with a gross profit margin close to 90% and sales profit margin[3] close to 60%. Sales profitability for product has been achieved.
  • Adjusted non-IFRS loss[4] for the period was RMB 92 million (US$ 12.9 million), with a decrease of about 3% compared to2024H1.
  • Net loss per share attributable to ordinary shareholders basic and diluted was RMB 0.41.
  • Cash and cash equivalents, term deposits and financial assets was RMB 603 million (US$ 84.6 million). Net cash used in operating activities was RMB 93 million (US$ 13 million), with a decrease of around 15% compared to 2024H1. Going forward, as commercialization progresses, the net operating cash outflow is expected to continue improving, enabling the Company to steadily transition into a virtuous cycle and rapid growth.

Note:

[1] Conversions from RMB to US$ is made at an exchange rate of RMB7.1651 to US$1.00, set forth in the H.10 statistical release of the Federal Reserve Board on August 22, 2025

[2] Defined as gross profit minus selling and distribution expenses

[3] Defined as sales profit/revenue

[4] The purpose of the adjusted non-IFRS loss for the period is to provide supplementary information for evaluating the Group’s operational performance by excluding the impact of share-based compensation expense and foreign exchange differences

 

Ecolab and SCG Sign MOU to Enhance Business Competitiveness and Drive ESG Progress Toward Net Zero

BANGKOK, Sept. 1, 2025 /PRNewswire/ — Ecolab, a global leader in water, hygiene, and infection prevention solutions and services, and SCG (Siam Cement Group), ASEAN’s leading business conglomerate, have signed a Memorandum of Understanding (MOU) in view of five year partnership to strengthen SCG’s competitiveness through efficiency gains and cost savings, while advancing its ESG strategy as a pathway to Net Zero. Running from June 2025 to May 2030, the agreement will help SCG reduce its greenhouse gas emissions and increase its water reuse ratio beyond the 13.10% baseline in 2024. This MOU builds on a 30-year partnership that continues to deliver impactful innovations in sustainability, efficiency, and environmental stewardship. 

SCG President and CEO, Thammasak Sethaudom & Ecolab Chairman and CEO, Christophe Beck
SCG President and CEO, Thammasak Sethaudom & Ecolab Chairman and CEO, Christophe Beck

Building on this foundation, the MOU focuses on outcomes that strengthen competitiveness — from optimizing water use to significantly cutting CO₂ emissions within the next five years, while improving efficiency to lower operational costs. Ecolab will partner with SCG Packaging (SCGP) and SCG Chemicals (SCGC) to explore potential initiatives that deliver more efficient and productive processes with high-quality output. Through innovative solutions and process improvements, operations will not only save water, reduce footprint, and enhance water quality, but also lower energy consumption, improve energy efficiency, and explore opportunities for renewable energy integration — ultimately driving sustainability impact alongside long-term business resilience.

Christophe Beck, Chairman and CEO of Ecolab, said, “For more than 30 years, Ecolab has been proud to support SCG and their sustainability journey. Our long-standing collaboration has been grounded in a shared belief that responsible business practices can both protect our planet and create long-term value for companies and communities.

Through our water solutions and process expertise, we’ve become a trusted partner that helps SCG deliver measurable outcomes. As we look ahead, we’re confident that our continued collaboration—powered by innovation and a focus on sustainable growth—will help accelerate SCG’s environmental ambitions and inspire progress across the broader industry. I look forward to seeing what we can accomplish together.”

Thammasak Sethaudom, President and Chief Executive Officer of SCG, said, “At SCG, we believe competitiveness and sustainability go hand in hand. This MOU with Ecolab is a strategic move that enables us to reduce costs, improve efficiency, and strengthen our resilience by increasing our water reuse ratio beyond 13.10% in 2024 and reducing greenhouse gas emissions, while advancing our ESG priorities as the foundation towards Net Zero 2050. Partnering with a global leader like Ecolab demonstrates how collaboration can create shared value through knowledge exchange and innovation at a world-class level. To begin, this collaboration will involve SCGP and SCGC, with the potential for other businesses to join as opportunities arise.”

Danaidej Ketsuwan, Chief Financial Officer, SCGP, added, “For SCGP, this partnership supports our commitment to deliver sustainable packaging solutions. By integrating circular design principles and resource efficiency with Ecolab’s expertise, we will create packaging that minimizes environmental impact and adds value for our customers and communities.”

Dr.Suracha Udomsak, Chief Operations and Innovation Officer, SCGC, added, “For SCGC, the collaboration is an opportunity to further advance water and energy efficiency across our operations. This collaboration aligns with SCGC’s sustainability commitment of ‘Low Waste, Low Carbon’, while strengthening our competitiveness.”

This five-year MOU underscores how collaboration between industry leaders can turn sustainability commitments into measurable outcomes, accelerating the journey toward Net Zero while strengthening competitiveness across industries.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets. www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

About SCG

SCG, now in its 112th year, is a leading business conglomerate in ASEAN. With strong resilience and advanced technology, the Company delivers innovative products, services, and solutions that meet diverse needs and adapt to fast-changing markets through its core businesses: Cement and Building Materials, Chemicals (SCGC), and Packaging (SCGP), as well as new businesses such as Clean Energy (SCG Cleanergy). Committed to improving quality of life and a sustainable future, SCG embeds ESG principles across Thailand, ASEAN, and globally, underpinned by trust, transparency, and its purpose of “Inclusive Green Growth.”

Follow us on Website https://www.scg.com/, LinkedIn @SCG, Instagram @scg.officialig and Facebook @ SCGofficialpage.

(Executives from left to right): SCGP CFO, Danaidej Ketsuwan; SCG Smart Living and SCG Distribution & Retail President, Wiroat Rattanachaisit; SCG Cement & Green Solution President, Surachai Nimlaor; SCGC Chief Operations and Innovation Officer, Dr.Suracha Udomsak; SCG President and CEO, Thammasak Sethaudom; Ecolab Chairman & CEO, Christophe Beck; SVP& Market Head, Greg Lukasik; Chief Marketing & Innovation Officer, Chris Leong, VP & GM for Basic Industries; Chandrasegaran Marimuthu and Strategic Account Director, Chroong Kanjchanapoomi
(Executives from left to right): SCGP CFO, Danaidej Ketsuwan; SCG Smart Living and SCG Distribution & Retail President, Wiroat Rattanachaisit; SCG Cement & Green Solution President, Surachai Nimlaor; SCGC Chief Operations and Innovation Officer, Dr.Suracha Udomsak; SCG President and CEO, Thammasak Sethaudom; Ecolab Chairman & CEO, Christophe Beck; SVP& Market Head, Greg Lukasik; Chief Marketing & Innovation Officer, Chris Leong, VP & GM for Basic Industries; Chandrasegaran Marimuthu and Strategic Account Director, Chroong Kanjchanapoomi

Jenscare, releases 2025H1 interim results

BEIJING, Sept. 1, 2025 /PRNewswire/ — Jenscare Scientific Co., Ltd. (“Jenscare” or the “Company”) (HKEX: 9877), an innovative medical device company with TTVR breakthroughs, achieved milestones in its product portfolio globally, and just released its interim results for 2025H1 ended June 30, 2025.

Business Overviews:

In 2025H1, significant progress was achieved across its product pipeline in the interventional treatment for tricuspid, aortic and mitral valve diseases, establishing a diversified and high-potential product portfolio. More importantly, the Company continued to expand its global business layout, enhancing product influence and clinical application scale, thereby laying a solid foundation for sustainable high-speed growth.

The global registration and clinical progress of LuX-Valve Plus TTVR system achieves key milestones in China, Europe, and U.S.

In China, the multicenter registration clinical trial of LuX-Valve Plus is in the long-term follow-up phase and shows excellent clinical results. Randomized controlled trial (RCT) of optimized medical therapy (OMT) conducted in China has completed subject enrollment. The application for NMPA registration has been submitted and accepted, entering registration review stage. The Company is actively advancing the NMPA registration process of LuX-Valve Plus and strives to obtain the NMPA registration certificate soon.

In Europe, LuX-Valve Plus has completed 6-month follow-up of the global multicenter clinical trial TRINITY Study for CE Marking and is currently under registration review. The 30-day clinical follow-up results of TRINITY Study were officially released at EuroPCR 2025, indicating favorable clinical results. The 30-day clinical follow-up results in large annulus patients in the TRNITY Study were released at New York Valves 2025. The results showed that both groups of patients (large annulus patients and small annulus patients) demonstrated outstanding outcomes. The wide range of application of LuX-Valve Plus provides an excellent treatment option, particularly for patients of annular dilation with severe TR. The 6-month follow-up outcome of TRINITY Study is expected to be released at TCT 2025.

In the United States, LuX-Valve Plus was selected to participate in the FDA’s Total Product Life Cycle Advisory Program (TAP) pilot. Its FDA IDE early feasibility study (EFS) has completed subject enrollment and has received reimbursement for device and related costs from CMS. The Company is actively advancing the progress to obtain approval for the Pivotal Study.

The commercialization of Ken-Valve TAVR system is advancing rapidly, with continuous growth in both hospital coverage and implantations

Ken-Valve has quickly gained market access after its approval by NMPA in 2025H1. The Company has been actively promoting the commercialization activities with smooth progress in hospital adoption. Commercial implantations are being actively conducted across the country.

Ken-Valve has received plenty of positive feedbacks regards its innovative design, operational performance, and clinical efficacy. It is a rare product that is indicated for severe AR (or combined with AS) to meet large underpenetrated clinical needs. Its innovative design accommodates a wide range of complex anatomies, significantly improving procedural safety and flexibility while reducing device operation time. The large-size valves of 29mm, 31mm, and 33mm have been widely recognized by physicians and the market, addressing the unmet clinical need for large-annulus patients. It is also suitable for patients with challenging anatomies, such as severe horizonal heart. The average device operation time was less than 10 minutes, with the shortest being around 4 minutes during the commercialization phase.

We will continue to advance the commercialization of Ken-Valve, leveraging its differentiated competitive advantages, supply chain strengths, and flexible marketing strategies to provide the Company with stable revenue and profits.

JensClip TMVr system has submitted its NMPA registration application

JensClip has submitted its NMPA registration application, entering the registration stage. The one-year clinical follow-up results were released at EuroPCR 2025, showing encouraging efficacy and safety indicators.

The globalization process is being actively pursued. Pre-commercialization implantations have been successfully conducted overseas, with all procedures progressing smoothly and the product demonstrating excellent performance. CE Marking activities are also underway

Global commercialization strategy

  • Differentiated Positioning of competitive product portfolio

Our product portfolio leverages diversified, innovative designs to address vast, under-penetrated, and rapidly growing markets. Through differentiated product positioning, we quickly build brand recognition; stable, user-friendly operation of the products rapidly establishes physician habits. Leveraging global KOLs and proctors with extensive experience and academic influence, we disseminate procedural skills and technical expertise via diverse academic conferences, live/recorded cases, and case discussions—radiating from leaders to regional centers to expand product awareness and hospital coverage at speed.

  • Global Sales Network

In China, we have established a comprehensive regional distributor network for Ken-Valve, supported by flexible pricing and sales strategies that allow agile, timely responses to market dynamics to accelerate commercialization and expand market share. Overseas, commercial preparations for LuX-Valve Plus are ongoing, with in-depth market research laying the groundwork for imminent market launch.

  • Professional Procedural Promotion

A dedicated, high-efficiency commercial team drives market entry, procedural education, and marketing for our products. Through high-standard on-site clinical support and feedback, we ensure consistently high-quality procedures worldwide, enhance customer satisfaction, and establish global procedural standards. Active participation in premier structural-heart conferences, associations, and annual conferences across the globe further elevates brand influence and academic standing.

  • Comprehensive Training System

We have built robust internal and external training programs that deliver thorough, professional instruction on product features, procedural techniques, imaging applications, perioperative management, and complex-case handling—accelerating procedural adoption both inside and outside the organization and driving rapid product penetration and market-share expansion.

Future Expectations

The Company will continue to advance the clinical and commercial development of multiple products, striving to become a high-potential medical device enterprise with a global vision and l business layout.

We will accelerate the worldwide rollout of the LuX-Valve series, aiming to set the leading benchmark in transcatheter tricuspid-valve intervention. Leveraging its global partnerships, clinical application experience, and brand reputation, the Company will extend overseas opportunities across its entire product portfolio.

To achieve sustainable rapid growth, we aim to further expand and optimize our product portfolio to address the substantial and urgent unmet clinical needs in structural heart disease treatment.

By further enhancing operational efficiency, rapidly capturing high-growth revenue and profit, and sustaining innovation, the Company will secure long-term success for its globalization strategy.

Financial Highlights: Steady Operation with High Quality of Growth

  • Total revenue was RMB 26 million (US$ 3.6 million)[1], marking a great start for commercialization. Gross profit and sales profit[2] was RMB 12 million (US$ 1.7 million) and RMB 8 million (US$ 1.1 million) respectively, with a gross profit margin close to 90% and sales profit margin[3] close to 60%. Sales profitability for product has been achieved.
  • Adjusted non-IFRS loss[4] for the period was RMB 92 million (US$ 12.9 million), with a decrease of about 3% compared to2024H1.
  • Net loss per share attributable to ordinary shareholders basic and diluted was RMB 0.41.
  • Cash and cash equivalents, term deposits and financial assets was RMB 603 million (US$ 84.6 million). Net cash used in operating activities was RMB 93 million (US$ 13 million), with a decrease of around 15% compared to 2024H1. Going forward, as commercialization progresses, the net operating cash outflow is expected to continue improving, enabling the Company to steadily transition into a virtuous cycle and rapid growth.

Note:

[1] Conversions from RMB to US$ is made at an exchange rate of RMB7.1651 to US$1.00, set forth in the H.10 statistical release of the Federal Reserve Board on August 22, 2025

[2] Defined as gross profit minus selling and distribution expenses

[3] Defined as sales profit/revenue

[4] The purpose of the adjusted non-IFRS loss for the period is to provide supplementary information for evaluating the Group’s operational performance by excluding the impact of share-based compensation expense and foreign exchange differences

 

Wellspring by Silks Beitou Now Fully Open with Complete Guest Services

Japanese “Okami”-Inspired Hospitality, Serene Architecture, and Urban Hot Springs Redefine Wellness Travel in Taipei

TAIPEI, Sept. 1, 2025 /PRNewswire/ — Silks Hotel Group is pleased to announce that Wellspring by Silks Beitou, the second property under its Wellspring by Silks brand, is now fully open and operating at full capacity following its grand opening earlier this year.

The lobby of Wellspring by Silks Beitou blends Zen-inspired architecture with contemporary design, offering guests a tranquil first impression of Taipei’s premier urban hot spring retreat.
The lobby of Wellspring by Silks Beitou blends Zen-inspired architecture with contemporary design, offering guests a tranquil first impression of Taipei’s premier urban hot spring retreat.

Located just a three-minute walk from Xinbeitou MRT Station, the hotel seamlessly combines Beitou’s renowned hot spring culture with refined Japanese-inspired hospitality and contemporary design. The property offers 100 guest rooms and suites, each equipped with twin soaking tubs supplied by Beitou’s signature white sulfur springs, along with 16 additional private hot spring rooms featuring windows that frame either mountain or city views.

Guests can enjoy an extensive range of facilities, including a communal bath, outdoor pool, spa treatment rooms, fitness center, children’s play areas, and the Gallery Lounge, which presents rotating art exhibitions. Dining highlights include Mihan Beitou, a contemporary Japanese hot pot restaurant, and Bando Club, a banquet-style venue offering traditional Taiwanese dishes and private dining experiences.

Certified to Golden-Level Green Building standards, the hotel underscores Silks Hotel Group’s commitment to sustainability. Guests may also take part in curated wellness activities developed in partnership with the Japan Sustainable Tourism Association, ensuring a more meaningful and immersive stay.

Architecture & Design

Inspired by Beitou’s hot spring heritage, the hotel’s architecture emphasizes natural textures and serene spaces. Guest rooms are infused with Zen-inspired aesthetics, bespoke Taiwanese ceramic artworks, and views of either the mountains or the city. The two communal bath areas showcase contrasting atmospheres—one featuring dark volcanic stone, the other pale stone and wooden latticework—each evoking a different expression of nature.

Service with Soul

Wellspring by Silks Beitou is the first hotel in Taiwan to introduce certified Japanese Onsen Guides, who provide guests with insights into the health benefits and etiquette of Beitou’s unique hot springs. In collaboration with Guyo Ryokan, a century-old inn in Yamagata, the hotel also incorporates Japan’s traditional “Okami” culture of hospitality, training staff to deliver warm, intuitive, and personalized service.

With its prime location, elegant design, and dedication to East Asian wellness traditions, Wellspring by Silks Beitou is set to become a premier retreat for leisure travelers, wellness enthusiasts, and urban staycationers alike.

Banyan Group Marks Upcoming 100th Property Milestone with 100 Days of Global Celebrations

100 Journeys honours the people, places and communities behind the Group’s portfolio, culminating in a week-long festival in Singapore during the Grand Opening of Mandai Rainforest Resort by Banyan Tree

SINGAPORE, Sept. 1, 2025 /PRNewswire/ — Banyan Group (“Banyan Tree Holdings Limited” or the “Group” – SGX: B58), an independent global hospitality company, today unveiled 100 Journeys – a hundred days of global celebrations across its portfolio in the lead-up to the grand opening of its 100th property. This milestone reflects three decades of growth and purpose-driven hospitality, from the Group’s first resort in Phuket to 100 resorts and hotels under 12 brands across 20 destinations, including its latest landmark, Mandai Rainforest Resort by Banyan Tree in Singapore.

Discover 100 Journeys: Mandai Rainforest Resort by Banyan Tree  [Photo Credit: Mandai Wildlife Reserve & WOW Architects]
Discover 100 Journeys: Mandai Rainforest Resort by Banyan Tree [Photo Credit: Mandai Wildlife Reserve & WOW Architects]

Honouring the people, places, and communities that have shaped Banyan Group’s portfolio over the years, the celebrations will culminate in a week-long festival at Mandai Rainforest Resort from 27 November to 3 December 2025, featuring discovery trails, wellbeing sessions, and community activities. Driven by Banyan Group’s commitment to stewardship and shared impact, and supported by the Group’s corporate partners, proceeds from the festival tickets will be matched 1:1 by Banyan Group and donated to the President’s Challenge, an annual initiative led by the President of Singapore to support local charities and social service organisations.

“As we celebrate the Grand Opening of our 100th property later in November, 100 Journeys reflects how far we’ve come and how we’ve grown,” said Ren Yung Ho, Deputy Chief Executive at Banyan Group. “It’s a tribute to the communities that shaped us and a promise to continue creating meaningful, place-led experiences that stay with our guests long after the journey ends. The Banyan experience has always been rooted in care – for people, for place, and for purpose. It redefines the value of travel as something measured in the lasting connections formed and new perspectives gained”.

100 Journeys: Celebrating Shared Stories, Personal Discoveries, and Lasting Impact

Running from 1 September to 9 December 2025, 100 Journeys is a global celebration of shared stories, personal discoveries, and lasting impact shaped by guests, associates, and communities. Each destination invites travellers to engage in authentic cultural exchanges, make personal discoveries, and experience how thoughtful hospitality supports local communities, with every property contributing to a larger narrative of respectful exploration and collective storytelling.

100 Discoveries: Discovery of Place

Across its portfolio of resorts and hotels, Banyan Group has curated 100 experiences that immerse travellers in the culture and character of each location.

Highlights include Tibetan black pottery-making at Banyan Tree Ringha, cooking local meals at Cassia Phuket, and practicing zen meditation at a temple near Banyan Tree Higashiyama Kyoto. Guests may also explore ancient rock formations at Banyan Tree AlUla, stroll through Vietnam’s golden rice terraces at Garrya Mu Cang Chai, join bamboo rafting at Banyan Tree Yangshuo, or dive a sunken shipwreck in the Maldives at Dhawa Ihuru. At Mandai Rainforest Resort by Banyan Tree, new nature and photography workshops celebrate Singapore’s biodiversity, while at Angsana Corfu, guided eco-walks through olive groves and historic trails invite guests to give back to nature through mindful conservation. Each discovery is crafted to spark curiosity, deepen cultural understanding, and inspire personal reflection.

100 Impacts: Discovery through Stewardship

Guided by the ethos of “Embracing the Environment, Empowering People”, Banyan Group integrates its business with natural and cultural heritage while building partnerships that create meaningful impact across its destinations. These efforts come to life through the voices of associates and communities who embody and advance this mission.

In the Maldives, the refreshed Marine Lab engages guests in coral conservation and marine education. In China, the Group supports bird conservation near Banyan Tree Suzhou, where more than 170 species now thrive. On Bintan Island, over 5,800 sea turtles have been released since 2008, alongside guest-led rewilding tours.

The Group’s commitment extends beyond conservation. Initiatives include clean water access for villages near Banyan Tree Yangshuo, artisan collaborations through Banyan Tree Gallery, and youth mentorship via the Seedlings Programme, which equips young people with education and vocational skills. Through the Stay for Good initiative, guests are also encouraged to participate in community engagement that honours culture and fosters meaningful exchange.

100 Stories: Discovery Through the Eyes of Others

At the heart of 100 Journeys are the voices of guests, associates, and communities. Through digital postcards and personal reflections, 100 Stories captures moments of transformation and connection that define the travel experience.

Between 1 September and 9 December 2025, guests are invited to contribute their own stories to this growing library of memories. A hundred submissions will be recognised with a USD100 Banyan Group e-gift card, and the top three storytellers will receive a complimentary three-day, two-night stay.

Visit www.groupbanyan.com to learn more about 100 Journeys.

For high-resolution images, please download here

ABOUT BANYAN GROUP

Banyan Group (“Banyan Tree Holdings Limited” or the “Group” – SGX: B58) is an independent, global hospitality company with purpose. The Group prides itself on its pioneering spirit, design-led experiences and commitment to responsible stewardship. Its extensive portfolio spans over 90 hotels and resorts, more than 140 spas and galleries, and 20 plus branded residences in over 20 countries. Comprising 12 global brands, including the flagship brand Banyan Tree, each distinct yet united under the experiential membership programme withBanyan. The founding ethos of “Embracing the Environment, Empowering People” is embodied through the Banyan Global Foundation and Banyan Academy. Banyan Group is committed to remaining the leading advocate of sustainable travel, with a focus on regenerative tourism and innovative programmes that elevate the guest experience.

Aon Appoints Bonjay Koo as Enterprise Client Leader for South Korea


SEOUL, SOUTH KOREA – Media OutReach Newswire – 1 September 2025 Aon plc (NYSE: AON), a leading global professional services firm, today announced Bonjay Koo has been appointed Enterprise Client Leader, Asia Pacific in South Korea effective September 1.

Bonjay Koo
Bonjay Koo

In this strategic role, Koo will be responsible for the delivery of integrated Risk Capital and Human Capital solutions to Aon’s enterprise and large multinational clients across South Korea. Koo will be based in Seoul and report to Craig Torgius, chief client officer and head of enterprise clients, Asia Pacific and work closely with Kevin Kim, CEO for Korea at Aon.

“We are thrilled to welcome Bonjay to Aon,” said Torgius. “His strategic insight, collaborative leadership and proven track record in managing complex client engagements make Bonjay the ideal fit. Bonjay’s appointment reflects Aon’s commitment to bringing an integrated, enterprise-wide approach to clients across all geographies. His deep c-suite relationships and nuanced understanding of client strategy position him to unlock new opportunities and bring together cross-functional teams to deliver exceptional outcomes for Aon’s clients.”

With over 30 years of professional experience, including more than two decades in top-tier consulting firms, Koo brings a wealth of expertise in financial services and beyond. His career spans leadership roles at Deloitte Consulting, Oliver Wyman, Kearney and Arthur D. Little, where he advised major Korean conglomerates on business strategy, digital transformation, M&A and operational excellence.

Commenting on his appointment, Koo said: “I am honoured to join Aon and excited to drive outstanding client results. I look forward to engaging with Korea’s leading organisations to help them navigate complex challenges leveraging Aon’s data and expertise.”

Read more about Aon’s capabilities in Asia Pacific here.

Hashtag: #Aon

The issuer is solely responsible for the content of this announcement.

About Aon

(NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.

Follow Aon on , , and . Stay up to date by visiting Aon’s and sign up for news alerts .

Bybit Presents “Mantle × Bybit Roadmap”: Expanding MNT Utilities and Vision for Mass Adoption

DUBAI, UAE, Sept. 1, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, presented the “Mantle × Bybit Roadmap“, outlining the next stage in the development of $MNT and its integration across Bybit’s ecosystem.

This announcement builds on the recent appointment of Bybit Co-CEO Helen Liu and Head of Spot Emily Bao — also the founder of Byreal — as key advisors to Mantle. Their involvement reflects a deeper alignment between Bybit and Mantle to accelerate Layer 2 infrastructure and position MNT as a bridge between Web2 and Web3.

Mantle × Bybit Roadmap: Phased Rollout

What began as a single token has now become a broader force within Bybit, powering use cases from trading to payments and savings. With Mantle 2.0, MNT is set to unlock even greater opportunities for users around the world, serving as a bridge between digital assets, real-world applications, and institutional adoption.

The roadmap details how MNT utilities will expand in waves through August, September, and beyond:

  • Buy  — Currently available through spot trading, Convert, OTC with fixed pricing, and Bybit’s auto-invest bot. Starting late September, “Discount Buy” will launch with support for lockup products at reduced prices.
  • Use — From September, spot pairs will expand from 4 to over 20. By late September, MNT can be used to pay trading fees (25% off Spot, 10% off Derivatives), card payments with zero conversion fee, and Web3 purchases. Options trading and access to VIP events and merchandise with MNT are also planned.
  • Hold — From early September, institutional users will unlock higher leverage (up to 8x) and extended fixed-loan terms. Later in the month, retail users will gain multipliers for faster VIP upgrades and enhanced cashback via Bybit Card & Pay.
  • Earn — Fixed-term savings roll out at the end of August, alongside higher allocations for new token launches (e.g., HODLVerse, Launchpool, and Megadrop). Users can also access flexible savings, dual asset products, and liquidity mining.
  • Limited Offers — Ongoing campaigns like MNT Puzzle Hunt and Wednesday Airdrops will be joined by regional cashback promotions (end of September) and a Mantle-themed anniversary celebration in October.

The phased rollout aims to make MNT more than a speculative asset — embedding it into daily trading, payments, and wealth management for both institutional and retail users. By supporting real-world and Web3 payments, expanding trading options, and tying MNT to membership privileges, the roadmap brings Mantle closer to its mission of driving meaningful adoption.

#Bybit / #TheCryptoArk  /#IMakeIt

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 70 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube